FDA Brief

Warning letters Devices

FDA warning letter to

Integra LifeSciences Corporation

High riskIssued Jul 17, 2023Posted Aug 15, 2023Division of Medical Device and Radiological Health Division I

FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.

What happened

FDA inspected TEI Biosciences, an Integra LifeSciences company, in Boston, MA, from March 1 through May 17, 2023. FDA found the collagen-based devices were adulterated (not meeting legal manufacturing requirements) because manufacturing and quality controls did not meet the Quality System regulation. The company recalled all finished goods within expiry manufactured from March 1, 2018 through May 22, 2023, and committed not to distribute until the site was in substantial conformity.

What FDA found

  1. Failed to have procedures to control product that did not meet specifications; a Durepair lot was released despite a bacterial endotoxin result above the limit.

    21 CFR 820.90(a)
  2. Failed to have effective corrective and preventive action procedures; a complaint led to a hold, but actions were not opened for all issues, including endotoxin.

    21 CFR 820.100(a)(1)
  3. Failed to adequately validate test methods for bacterial endotoxin and bioburden testing.

    21 CFR 820.75(a)
  4. Failed to store devices to allow proper stock rotation and assess condition; sterile implantable lots labeled non-sterile were on an unsecure open shelf in quarantine.

    21 CFR 820.150(a)

What FDA wants

FDA asks the company to respond in writing within 15 business days with the specific steps and corrective actions it has taken or plans to take to prevent recurrence. It also requests certification by an outside expert consultant that an audit of manufacturing and quality assurance systems was conducted, with initial certifications due March 31, 2024.

Who should pay attention

  • hospitals and surgeons implanting collagen-based devices
  • distributors and buyers of recalled Integra/TEI products
  • other medical device manufacturers with collagen or implantable products

This is a summary. Read the original letter on fda.gov.

Integra LifeSciences Corporation's FDA history

  1. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over bacterial toxin test and sterilization failures at three medical device plants.

    High risk

Full company page

Similar letters to other companies

  1. Olympus Medical Systems Corporation

    FDA warns Olympus over quality-system failures across six medical device plants, including unvalidated designs and released nonconforming devices.

    High risk
  2. Physitemp Instruments, LLC

    FDA says Physitemp sold clinical thermometers and temperature probes without FDA clearance and with unvalidated sterilization and welding.

    High risk
  3. Longhorn Vaccines and Diagnostics LLC

    Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.

    High risk
  4. Avertix Medical, Inc.

    FDA warns Avertix Medical over Guardian implantable cardiac event detector quality violations and late injury reports.

    High risk